Re:Anti-obesity drugs' side effects: what we know so far
by penjelly on Monday October 16, 2023 @12:26PM
(#37902204)
> The authors found that the incidence of pancreatitis — inflammation of the pancreas — was 4.6 times higher in people taking semaglutide than in people taking a weight-loss medication that does not mimic GLP-1. The study also found that semaglutide and liraglutide, another GLP-1 medication, were associated with an increased incidence of gastroparesis, a disorder that slows or stops the movement of food from the stomach to the intestine.
also theyre a bit worried about people becoming obese while having low muscle mass, so an obese skinny person?
Re:Anti-obesity drugs' side effects: what we know so far
by local_crmdgeon on Monday October 16, 2023 @01:26PM
(#37903190)
Obesity with low muscle mass is sedentary obesity. It's the worst kind but also the most common form - the "dad bod" type of big-gut-big-arms is a smaller chunk of the pie than the "walmart power scooter" type.
It's all horrible, I'm convinced it's microplastics, and we need to get oral GLP-1 drugs ASAP.
also theyre a bit worried about people becoming obese while having low muscle mass, so an obese skinny person?
It's all horrible, I'm convinced it's microplastics, and we need to get oral GLP-1 drugs ASAP.